Remove section arts design
article thumbnail

Study suggests ways to improve future HIV vaccine candidates

Drug Discovery World

The researchers drew comparisons between the immune system activity of past HIV vaccine study participants and people with HIV who naturally keep the virus from replicating even in the absence of antiretroviral therapy (ART), called ‘long-term non-progressors’ or ‘elite controllers’ (LTNPs/ECs).

article thumbnail

Wonder Group Gains $100 Million Boost from Nestlé

XTalks

Food delivery startup Wonder Group has received a substantial financial boost from Nestlé, underscoring the company’s initiative to revolutionize the culinary landscape with state-of-the-art kitchen technology and pre-prepared ingredients catered to businesses like hotels, hospitals and sports arenas. billion in 2016.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

AbbVie, Evolus, and Medytox Announce Resolution of Intellectual Property Litigation

The Pharma Data

botulinum and concluded that a violation of Section 337 of the Tariff Act of 1930 had occurred. Food and Drug Administration approved Jeuveau® (prabotulinumtoxinA-xvfs), the first and only neurotoxin dedicated exclusively to aesthetics and manufactured in a state-of-the-art facility using Hi-Pure technology.

article thumbnail

Leading Microbiome Researcher Dr. Eric Pamer Joins Diversigen’s Scientific Advisory Board

The Pharma Data

Professor of Medicine, Section of Infectious Diseases and Global Health and director of the Duchossois Family Institute at the University of Chicago, has joined its scientific advisory board. PAUL, Minn., 25, 2021 (GLOBE NEWSWIRE) — Diversigen, Inc. , a subsidiary of OraSure Technologies Inc. Diversigen, Inc.

article thumbnail

Coalition issues rallying cry to takes the fight against AMR to the front line

pharmaphorum

As COVID clearly demonstrated, no one section of the healthcare community – whether that’s clinicians, advocacy groups, or industry – can solve a wholescale public health emergency alone.

article thumbnail

What to expect from PEGS Europe 2023: Day 3

Drug Discovery World

Enkelejda Miho, PhD, Professor, University of Applied Sciences and Arts Northwestern Switzerland, and Managing Director, aiNET, on: ‘The singular immune response to dengue and machine learning identification of antibodies in high-throughput sequences’.

Protein 59
article thumbnail

Radius Health, Inc. Announces Acquisition of Orphan Disease Program

The Pharma Data

Prader-Willi syndrome (“PWS”) will be the initial indication, which has been granted Orphan Drug and Fast Track Designation by the FDA. The study design will be informed by learnings from previous clinical studies that have been conducted in the PWS patient population. Benuvia Therapeutics Inc.